Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Brain Neoplasms × pembrolizumab × Clear all

Phase

Phase 2 15 Phase 1/2 7 Phase 1 7 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 CNS 1

Conditions

Parkinson Disease 4, Autosomal Dominant Lewy Body 80 Carcinoma, Non-Small-Cell Lung 71 Lung Neoplasms 18 Melanoma 15 Squamous Cell Carcinoma of Head and Neck 14 Triple Negative Breast Neoplasms 10 Stomach Neoplasms 10 Carcinoma, Renal Cell 10 Breast Neoplasms 9 Neoplasms 8 Neoplasm Metastasis 8 Head and Neck Neoplasms 8 Carcinoma 8 Endometrial Neoplasms 7 Urinary Bladder Neoplasms 6 Carcinoma, Hepatocellular 6 Colorectal Neoplasms 5 Carcinoma, Transitional Cell 5 Uterine Cervical Neoplasms 4 Prostatic Neoplasms 4 Esophageal Neoplasms 4 Cholangiocarcinoma 4 Thoracic Neoplasms 3 Respiratory Tract Neoplasms 3 Respiratory Tract Diseases 3 Ovarian Neoplasms 3 Neoplasms by Site 3 Lung Diseases 3 Gallbladder Neoplasms 3 Fallopian Tube Neoplasms 3

Interventions

Radiosurgery 21 Radiotherapy 19 Temozolomide 15 Lomustine 8 Bevacizumab 7 Surgical Procedures, Operative 6 Procarbazine 6 Vincristine 5 Nivolumab 5 Memantine 4 Filgrastim 4 Etoposide 4 Cisplatin 4 Carboplatin 4 Sodium Chloride 3 Radiation 3 Magnetic Resonance Spectroscopy 3 Granulocyte Colony-Stimulating Factor 3 Cyclophosphamide 3 Corticotropin-Releasing Hormone 3 icotinib 2 etoposide phosphate 2 efaproxiral 2 X-Rays 2 Tranexamic Acid 2 Tf-CRM107 2 Specimen Handling 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy, Conformal 2 Platinum 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05317858 2025-12-10

LIMITLESS

InSightec

Phase 3 Recruiting

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡